Type 2 Diabetes Trial, Recruiting NCT06810635 Sponsor: University Hospital, Ghent Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT06810635
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 40 and 85 years old
  • You have a body mass index (a measure of body weight relative to height) between 18.5 and 30, which is considered normal to slightly overweight
  • You do not have metabolic syndrome (a cluster of conditions like high blood pressure, high blood sugar, and excess belly fat together)
  • You do not have diabetes (for the comparison group)
  • You have been diagnosed with type 2 diabetes for at least 2 years (for the diabetes group)
  • Your diabetes medications have stayed the same for at least 1 month

Who may not be able to join:

  • You are currently pregnant or breastfeeding
  • You have taken antibiotics, prebiotics, or probiotics in the last month
  • You have started a new medication or dietary supplement in the last month
  • You have made major changes to your diet recently
  • You have made major changes to your lifestyle recently
  • You have inflammatory bowel disease or other gastrointestinal conditions
  • You have had bariatric (weight-loss) surgery
  • You have another type of diabetes such as type 1 diabetes, cystic fibrosis-related diabetes, or a genetic form called MODY
  • You have significant heart problems or have previously had a heart attack or stroke
  • You have serious liver disease such as NASH or cirrhosis
  • You have severe lung disease such as advanced COPD or cystic fibrosis
  • Your thyroid condition has been uncontrolled in the past 6 months
  • You take blood-thinning medications such as warfarin or direct oral anticoagulants (confirm with trial site)
  • You are currently receiving chemotherapy or immunotherapy for cancer
  • You take immunosuppressant medications, such as those used after an organ transplant
  • You take anti-epileptic (anti-seizure) medications

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Bruno Lapauw, Professor, University Hospital, Ghent

Phone: 003293328967

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital, Ghent
Registry
ClinicalTrials.gov
Start date
4 March 2026
Est. completion
1 November 2028

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Differences in polyphenol metabolites in morning urine in persons with type 2 diabetes and in healthy controls.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov